Jeffrey S. Heier
OCULJeffrey S. Heier serves as officer: Chief Scientific Officer at Ocular Therapeutix, Inc. (OCUL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Jeffrey S. Heier's Insider Trading at Ocular Therapeutix, Inc. (OCUL)
Buys
1 · $45.8K
Sells
10 · $426.1K
Total Shares Bought
15,000
Total Shares Sold
46,307
Related Insiders
Todd Anderman
officer: Chief Legal Officer
OCULSell · Oct 13, 2026
Peter Kaiser
officer: Chief Development Officer
OCULSell · Oct 6, 2026
Donald Notman
officer: Chief Operating Officer
OCULSell · Sep 2, 2026
Sanjay Nayak
officer: Chief Strategy Officer
OCULSell · Aug 26, 2026
Pravin Dugel
See Remarks
OCULSell · Aug 26, 2026
Nadia Waheed
officer: Chief Medical Officer
OCULSell · Jun 5, 2026
Namrata Saroj
Chief Business Officer
OCULSell · Nov 7, 2025